SYNLOGIC INC (SYBX) Stock News
NASDAQ:SYBX - Nasdaq - US87166L2097 - Common Stock - Currency: USD
SYBX Latest News, Press Relases and Analysis
Synlogic Reports Third Quarter 2024 Financial Results
Synlogic Reports Third Quarter 2024 Financial Results
WINCHESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform...
SYBX Stock Earnings: Synlogic Beats EPS for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Synlogic (NASDAQ:SYBX) just reported results for the second quarter of 2024.Syn...
SYBX Stock Earnings: Synlogic Beats EPS for Q2 2024
SYBX stock results show that Synlogic beat analyst estimates for earnings per share the second quarter of 2024.
Synlogic Reports Second Quarter 2024 Financial Results
Why Synlogic (SYBX) Stock Is Down Nearly 50% Today
Synlogic shares are trading lower by 48.4% to $1.78 Friday afternoon. The company announced it will discontinue Synpheny-3, cease operations and reduce its workforce by more than 90%.
Why Is Synlogic (SYBX) Stock Down 55% Today?
Synlogic stock is falling hard on Friday with heavy trading of SYBX shares after the discontinuation of a clinical trial.
Synlogic Reports Second Quarter 2024 Financial Results
WINCHESTER, Mass., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform...
The Summer Stock Exodus: 3 Companies to Ditch Before the Heat Hits
Are you a firm believer of "sell in May and go away?" If so, check out the top stocks to sell heading into the summer season.
SYBX Stock Earnings: Synlogic Misses EPS, Misses Revenue for Q1 2024
SYBX stock results show that Synlogic missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Synlogic Reports First Quarter 2024 Financial Results
Synlogic Reports First Quarter 2024 Financial Results
CAMBRIDGE, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform...
Synlogic Reports Fourth Quarter and Full Year 2023 Financial Results
CAMBRIDGE, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform...
Synlogic Reports Fourth Quarter and Full Year 2023 Financial Results
Synlogic Adopts Limited Duration Stockholders Rights Plan
Engages Ladenburg Thalmann as financial advisor to assist with previously announced strategic review process
Synlogic Adopts Limited Duration Stockholders Rights Plan
Engages Ladenburg Thalmann as financial advisor to assist with previously announced strategic review process...
Synlogic shares crater amid company shut down, failed drug study (NASDAQ:SYBX)
Synlogic (SYBX) stock was trading nearly 50% lower midday Friday, the day after the company announced it was pulling the plug on its lead drug program and shutting down operations.
Why Is CleanSpark (CLSK) Stock Up 27% Today?
CleanSpark stock is rising higher on Friday as investors in CLSK shares celebrate the company's positive Q1 earnings report.
Why Is BioXcel Therapeutics (BTAI) Stock Down 26% Today?
BioXcel Therapeutics stock is falling on Friday after the company announced plans for a proposed public offering of BTAI shares.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!
Synlogic to discontinue lead drug program, cease operations (NASDAQ:SYBX)
Synlogic (SYBX) said it has decided to cease operations after determining that a key clinical study for its drug SYNB1934 in the treatment of phenylketonuria wo
Synlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate Update
Decision to end trial follows internal review of initial data indicating study unlikely to meet primary endpoint Data review found treatment to be safe...
Synlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate Update
Synlogic Announces Publication of Preclinical and Clinical Data for SYNB1353 as a Potential Treatment for Classical Homocystinuria
Findings support positive proof of mechanism, through successful degradation of methionine, precursor to homocysteine, using dietary disease model in...
Synlogic Provides Corporate Update and Outlook for 2024
- Data review from pivotal Synpheny-3 study in PKU expected in H1 2024, with potential to expand study population to patients aged 12-17 years of age - -...
Synlogic Provides Corporate Update and Outlook for 2024
Synlogic bags contract to develop live probiotic products (NASDAQ:SYBX)
Synlogic, a biotech company, has secured a contract with the Air Force Research Lab to develop live probiotic products.
Synlogic Announces Contract with the Air Force Research Lab
- Selection of Synlogic reflects Company’s leadership in process development and manufacturing of therapeutics based on synthetic biology -...
Synlogic Announces Contract with the Air Force Research Lab
- Selection of Synlogic reflects Company’s leadership in process development and manufacturing of therapeutics based on synthetic biology -